Company / Income Tax per Share
ANI Pharmaceuticals, Inc. Income Tax per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$0.83
FY2025
5-year range
-$1.07 / $0.83
FY2021-FY2025
Trend
+464.4%
vs FY2024
Sector context
#23 of 201
Health Care
What the data says
Income Tax per Share changed +464% YoY in FY2025, a notable deviation from the 9-year average annual change of -17%.
Based on SEC 10-K filings.
0.83 in FY2025. Top quartile in the Health Care sector.
Increased from $0.06 to $0.83 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 11% in Health CareTop 89% of 201This company $0.83 Sector average $1.35
▼
-38.7% below sector average
Key checks
Key Insights
- In FY2025, income tax per share increased 464.4% year-over-year.
- Ranks #23 out of 201 companies in the Health Care sector.
- Peak income tax per share was recorded in FY2017.
- Lowest income tax per share in the period was in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.83 | +464.4% |
| FY2024 | -$0.23 | -477.8% |
| FY2023 | $0.06 | +106.6% |
| FY2022 | -$0.91 | +15.0% |
| FY2021 | -$1.07 | -274.3% |
| FY2020 | -$0.29 | -12.2% |
| FY2019 | -$0.25 | -165.7% |
| FY2018 | $0.39 | -74.3% |
| FY2017 | $1.51 | +267.8% |
| FY2016 | $0.41 | -89.6% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026